Diabetes Prevention Clinical Trials

A listing of Diabetes Prevention medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 43 clinical trials
None
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardiovascular risk.

hemoglobin a1c
body mass index
cardiovascular disease
  • 643 views
  • 26 Nov, 2021
  • 914 locations
None
Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059)

This study will evaluate the safety and efficacy of ertugliflozin (MK-8835) in pediatric participants with T2DM on metformin with/without insulin. The primary hypothesis of the study is that the addition of ertugliflozin reduces hemoglobin A1C (HbA1C) more than the addition of placebo after 24 weeks of treatment.

hemoglobin a1c
insulin
metformin
body mass index
fasting
  • 277 views
  • 05 Dec, 2021
  • 108 locations
None
Investigation of Rifampin to Reduce Pedal Amputations for Osteomyelitis in Diabetics

The purpose of this research study is to determine if rifampin, an antibiotic (a medicine that treats infections), is effective in treating osteomyelitis (infection of the bone) of the foot in diabetic patients. Despite use of powerful antibiotics prescribed over a long period of time, many diabetic patients remain at …

oral hypoglycemic
insulin
hypoglycemic agents
rifampin
glycosylated hemoglobin
  • 514 views
  • 28 Nov, 2021
  • 30 locations
None
Study of Safety and Efficacy of CFZ533 in Type 1 Diabetes Pediatric and Young Adult Subjects

The study is a Phase 2, multicounty, multicenter, non-confirmatory, investigator- and subject masked, randomized, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of CFZ533 on preservation of residual pancreatic -cell function in new onset T1DM in pediatric and young adult subjects.

insulin
insulin treatment
glutamic acid
c-peptide
zinc
  • 27 views
  • 05 Dec, 2021
  • 12 locations
None
Comparative Effectiveness of Family vs. Individually Focused Diabetes Education and Support

The objective of this study is to compare the effectiveness of a novel program-Family Partners for Health Action (FAM-ACT) - to individual patient-focused diabetes self-management education and care management(I-DSME/CM).

diabetes
  • 0 views
  • 26 Nov, 2021
  • 2 locations
None
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight

This is a study of tirzepatide in participants with type 2 diabetes who have obesity or are overweight. The main purpose is to learn more about how tirzepatide affects body weight. The study will last 79 weeks (22 visits).

hemoglobin a1c
diabetes
glucagon-like peptide-1
glucagon
  • 96 views
  • 29 Nov, 2021
  • 98 locations
None
A Study of LY3502970 in Participants With Type 2 Diabetes Mellitus

The main purpose of this study is to evaluate the efficacy and safety of LY3502970 in participants with type 2 diabetes (T2D) who failed to achieve adequate glycemic control on diet and exercise alone or on a stable dose of metformin. This study will last about 30 weeks.

metformin
body mass index
type 2 diabetes mellitus
  • 6 views
  • 26 Nov, 2021
  • 47 locations
None
Diabetes Prevention Program (METFIT) in Reducing Insulin Resistance in Stage I-III Breast Cancer Survivors

This trial studies how well a diabetes prevention program (METFIT) works in reducing insulin resistance in stage I-III breast cancer survivors. METFIT program, a diet and lifestyle intervention

  • 0 views
  • 05 Dec, 2021
  • 1 location
None
A Study to Assess Safety of Canagliflozin and Metformin Hydrochloride Combination Given as a Supplement to Diet and Exercise to Improve Blood Sugar Level in Indian Adult Participants With Diabetes

The purpose of this study is to assess safety of canagliflozin + metformin hydrochloride immediate Release (IR) fixed-dose combination.

hemoglobin a1c
metformin
hypoglycemic agents
type 2 diabetes mellitus
sugars
  • 1 views
  • 24 Nov, 2021
  • 12 locations
None
People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

Background Chronic hepatitis C infects the liver. It may scar the liver. This is called cirrhosis and may lead to liver cancer or death. Current chronic hepatitis C treatments cure most people. But some keep getting complications even after it is cured. Researchers want to study why. Objective To study …

cancer
antiviral drugs
chronic hepatitis
hemophilia
interferon
  • 18 views
  • 03 Dec, 2021
  • 1 location